1/5 The Cumulative Risk of Substance Exposure and Early Life Adversity on Child Health Development and Outcomes
1/5 物质暴露和早年不幸对儿童健康发展和结果的累积风险
基本信息
- 批准号:10078664
- 负责人:
- 金额:$ 51.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-30 至 2022-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
PROJECT SUMMARY / DESCRIPTION
How do in utero opioid exposure and early adversity affect a child's neurodevelopmental and health outcomes?
The simplicity of this question masks the complex and multifaceted nature of human neurodevelopment, and the
variety of environmental influences that can exacerbate or moderate the effects of in utero substance exposure.
From conception to age 10, our brain undergoes remarkable structural and functional change. Processes
including myelination and synaptogenesis are at their peak throughout this age span, contributing to the
emergence of nearly all cognitive and behavioral skills, and responsive to both early substance exposures and
environmental stimuli. In the context of fetal opioid exposure, this often co-occurs with other maternal substance
use (alcohol, tobacco, marijuana), as well as related pre- and post-natal factors including maternal mental health
concerns, supportive or adverse family environments, low socioeconomic status (SES), inter-partner violence,
and caregiving quality and quantity. Despite increased efforts to understand the neurodevelopmental sequela of
in utero opioid and other substance exposure on long-term behavioral, cognitive, and societal outcomes,
important questions remain, specifically, 1. How is brain growth is disrupted by fetal substance and related pre
and post-natal exposures; and 2. How are these disrupted growth patterns causally related to later cognitive and
behavioral outcomes? This proposal seeks to formulate our approach to addressing these key questions, and
decipher the individual and cumulative effect of these intertwined pre- and post-natal exposures on child
neurodevelopment. By bringing together leading experts in child development and adversity, pediatric
neuroimaging, maternal, fetal, and child abuse medicine, longitudinal and functional statistics, and public health,
strategically located US states and counties hardest hit by the current opioid crisis, we will articulate our vision
of the larger HEALthy Brain & Child Development study, and lay the foundation for our participation in three
incremental steps. First, we will address the legal, ethical, and mother-child care and support concerns implicit
in this study by leveraging our team's past experience in family adversity, child abuse, and fetal substance
exposure research. Next, we will integrate across our areas of neuroimaging expertise to develop, implement,
and harmonize a multi-modal MRI and EEG protocol to assess maturing brain structure, function, and
connectivity. This neuroimaging protocol will be paired with extensive neurocognitive, sociodemographic,
physical health, family and medical history, anthropometric, and biospecimen data collection to quantify the
individual, cumulative, and interactive effects of a child's substance and environment on their overall health and
neurodevelopment. Finally, we will develop and test advanced statistical approaches to model and analyze this
multidimensional and longitudinal data, taking into account the likely sparse and unbalanced nature of the
measurements. Together, these steps lay the foundation for a broad and large-scale study to examine the
impact of exposure to substances and early adversity on a child's neural, physical, and behavioral development.
项目概要/描述
宫内阿片类药物暴露和早期逆境如何影响儿童的神经发育和健康结果?
这个问题的简单性掩盖了人类神经发育的复杂性和多面性,
各种环境影响可加剧或缓解宫内物质暴露的影响。
从怀孕到10岁,我们的大脑经历了显着的结构和功能变化。过程
包括髓鞘形成和突触发生在整个年龄段处于高峰,有助于
几乎所有认知和行为技能的出现,以及对早期物质暴露和
环境刺激在胎儿阿片类药物暴露的背景下,这通常与其他母体物质同时发生
使用(酒精、烟草、大麻)以及产前和产后相关因素,包括产妇心理健康
问题,支持或不利的家庭环境,社会经济地位低,伴侣间暴力,
和数量上的提高。尽管越来越多的努力来了解神经发育后遗症的
子宫内阿片类药物和其他物质暴露对长期行为、认知和社会结果影响,
重要的问题仍然存在,具体而言,1。胎儿物质和相关前体是如何干扰大脑生长的
和产后暴露;以及2.这些被打乱的生长模式与后来的认知和
行为结果?本建议旨在制定我们解决这些关键问题的方法,
解读这些交织在一起的产前和产后暴露对儿童的个体和累积影响
神经发育通过汇集儿童发展和逆境方面的顶尖专家,
神经影像学,孕产妇,胎儿和儿童虐待医学,纵向和功能统计,以及公共卫生,
我们将在战略上位于受当前阿片类药物危机打击最严重的美国各州和县,
更大规模的健康大脑与儿童发育研究的一部分,并为我们参与三项研究奠定基础
渐进的步骤。首先,我们将解决法律的,伦理,和母亲-儿童照顾和支持的关注隐含
在这项研究中,通过利用我们团队过去在家庭逆境、虐待儿童和胎儿物质方面的经验,
暴露研究。下一步,我们将整合我们的神经影像专业知识领域,以开发,实施,
并协调多模态MRI和EEG协议,以评估成熟的大脑结构,功能,
连通性。这项神经成像方案将与广泛的神经认知,社会人口统计学,
身体健康,家庭和病史,人体测量和生物标本数据收集,以量化
儿童的物质和环境对其整体健康的个体、累积和交互影响,
神经发育最后,我们将开发和测试先进的统计方法来建模和分析这一点
多维和纵向数据,同时考虑到
测量.总之,这些步骤为广泛和大规模的研究奠定了基础,
暴露于物质和早期逆境对儿童神经、身体和行为发育的影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STEPHEN L BUKA其他文献
STEPHEN L BUKA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STEPHEN L BUKA', 18)}}的其他基金
Mechanisms of Risk and Resilience to Age-Related Cognitive Decline: A 60-Year Prospective Prenatal Cohort
与年龄相关的认知衰退的风险和恢复力机制:60 年预期产前队列
- 批准号:
10063316 - 财政年份:2020
- 资助金额:
$ 51.37万 - 项目类别:
Mechanisms of Risk and Resilience to Age-Related Cognitive Decline: A 60-Year Prospective Prenatal Cohort
与年龄相关的认知衰退的风险和恢复力机制:60 年预期产前队列
- 批准号:
10631109 - 财政年份:2020
- 资助金额:
$ 51.37万 - 项目类别:
Mechanisms of Risk and Resilience to Age-Related Cognitive Decline: A 60-Year Prospective Prenatal Cohort
与年龄相关的认知衰退的风险和恢复力机制:60 年预期产前队列
- 批准号:
10428633 - 财政年份:2020
- 资助金额:
$ 51.37万 - 项目类别:
Mechanisms of Risk and Resilience to Age-Related Cognitive Decline: A 60-Year Prospective Prenatal Cohort
与年龄相关的认知衰退的风险和恢复力机制:60 年预期产前队列
- 批准号:
10256822 - 财政年份:2020
- 资助金额:
$ 51.37万 - 项目类别:
NATIONAL CHILDREN'S STUDY - PROVIDENCE COUNTY STUDY CENTER
全国儿童学习中心 - 普罗维登斯县学习中心
- 批准号:
8557292 - 财政年份:2012
- 资助金额:
$ 51.37万 - 项目类别:
The New England Family Study: Fifty Year Post-Perinatal Follow-Up for Life Course
新英格兰家庭研究:围产后五十年生命历程随访
- 批准号:
7943025 - 财政年份:2009
- 资助金额:
$ 51.37万 - 项目类别:
The New England Family Study: Fifty Year Post-Perinatal Follow-Up for Life Course
新英格兰家庭研究:围产后五十年生命历程随访
- 批准号:
7860152 - 财政年份:2009
- 资助金额:
$ 51.37万 - 项目类别:
Multigeneration Study of Nicotine Dependence Phenotypes
尼古丁依赖性表型的多代研究
- 批准号:
7729414 - 财政年份:2008
- 资助金额:
$ 51.37万 - 项目类别:
相似国自然基金
The Heterogenous Impact of Monetary Policy on Firms' Risk and Fundamentals
- 批准号:
- 批准年份:2024
- 资助金额:万元
- 项目类别:外国学者研究基金项目
基于移动健康技术干预动脉粥样硬化性心血管疾病高危人群的随机对照现场试验:The ASCVD Risk Intervention Trial
- 批准号:81973152
- 批准年份:2019
- 资助金额:54.0 万元
- 项目类别:面上项目
基于时间序列间分位相依性(quantile dependence)的风险值(Value-at-Risk)预测模型研究
- 批准号:71903144
- 批准年份:2019
- 资助金额:17.0 万元
- 项目类别:青年科学基金项目
RISK通路在胃泌素介导的心脏缺血再灌注损伤保护中的作用研究
- 批准号:81800239
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
异氟烷基于TLR4/RISK/NF-κB调控糖尿病缺血性脑卒中后NLRP3炎症小体形成的机制研究
- 批准号:81771232
- 批准年份:2017
- 资助金额:54.0 万元
- 项目类别:面上项目
Notch1与RISK/SAFE/HIF-1α信号通路整合在I-postC保护中的作用及其机制
- 批准号:81260024
- 批准年份:2012
- 资助金额:50.0 万元
- 项目类别:地区科学基金项目
相似海外基金
3/5 The Cumulative Risk of Substance Exposure and Early Life Adversity on Child Health Development and Outcomes
3/5 物质暴露和早年不幸对儿童健康发展和结果的累积风险
- 批准号:
10017414 - 财政年份:2019
- 资助金额:
$ 51.37万 - 项目类别:
THE CUMULATIVE RISK OF SUBSTANCE EXPOSURE AND EARLY LIFE ADVERSITY ON CHILD HEALTH DEVELOPMENT AND OUTCOMES
物质暴露和早期生活逆境对儿童健康发展和结果的累积风险
- 批准号:
9900281 - 财政年份:2019
- 资助金额:
$ 51.37万 - 项目类别:
2/5 The Cumulative Risk of Substance Exposure and Early Life Adversity on Child Health Development and Outcomes
2/5 物质暴露和早年不幸对儿童健康发展和结果的累积风险
- 批准号:
10017367 - 财政年份:2019
- 资助金额:
$ 51.37万 - 项目类别:
4/5 The Cumulative Risk of Substance Exposure and Early Life Adversity on Child Health Development and Outcomes
4/5 物质暴露和早年不幸对儿童健康发展和结果的累积风险
- 批准号:
9898607 - 财政年份:2019
- 资助金额:
$ 51.37万 - 项目类别:
4/5 The Cumulative Risk of Substance Exposure and Early Life Adversity on Child Health Development and Outcomes (Administrative Supplement)
4/5 物质暴露和早期生活逆境对儿童健康发展和结果的累积风险(行政补充)
- 批准号:
10373461 - 财政年份:2019
- 资助金额:
$ 51.37万 - 项目类别:
2/5 The Cumulative Risk of Substance Exposure and Early Life Adversity on Child Health Development and Outcomes
2/5 物质暴露和早年不幸对儿童健康发展和结果的累积风险
- 批准号:
10199299 - 财政年份:2019
- 资助金额:
$ 51.37万 - 项目类别:
4/5 The Cumulative Risk of Substance Exposure and Early Life Adversity on Child Health Development and Outcomes
4/5 物质暴露和早年不幸对儿童健康发展和结果的累积风险
- 批准号:
10170530 - 财政年份:2019
- 资助金额:
$ 51.37万 - 项目类别:
3/5 The Cumulative Risk of Substance Exposure and Early Life Adversity on Child Health Development and Outcomes
3/5 物质暴露和早年不幸对儿童健康发展和结果的累积风险
- 批准号:
9900258 - 财政年份:2019
- 资助金额:
$ 51.37万 - 项目类别:
2/5 The Cumulative Risk of Substance Exposure and Early Life Adversity on Child Health Development and Outcomes
2/5 物质暴露和早年不幸对儿童健康发展和结果的累积风险
- 批准号:
9899486 - 财政年份:2019
- 资助金额:
$ 51.37万 - 项目类别:
1/5 The Cumulative Risk of Substance Exposure and Early Life Adversity on Child Health Development and Outcomes
1/5 物质暴露和早年不幸对儿童健康发展和结果的累积风险
- 批准号:
10194823 - 财政年份:2019
- 资助金额:
$ 51.37万 - 项目类别:














{{item.name}}会员




